US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist

2.060
+0.100+5.10%

Close May 1 16:00 ET

2.040
-0.020-0.97%

Post 19:56 ET

233.81MMarket Cap-814P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

27.47%-174.88M

87.06%-12.94M

-46.40%-54.3M

22.23%-38.92M

-27.18%-68.73M

-544.17%-241.12M

-91.03%-99.95M

-370.51%-37.09M

-26,515.43%-50.04M

-4,053.55%-54.05M

Net income from continuing operations

18.46%-237.89M

-35.30%-79.65M

54.25%-39.64M

14.52%-42.87M

21.18%-75.73M

-1.62%-291.75M

-28.75%-58.87M

-124.90%-86.65M

-67.73%-50.15M

44.44%-96.08M

Operating gains losses

----

--6.22M

--0

--6.22M

Depreciation and amortization

2.49%3.79M

1.24%1.06M

-9.65%899K

-0.79%880K

23.73%949K

7.09%3.7M

25.60%1.05M

11.55%995K

1.14%887K

-9.66%767K

Other non cash items

-92.29%3.39M

-67.86%477K

-22.33%1.24M

-70.70%468K

-96.92%1.21M

-69.27%43.96M

24.29%1.48M

-16.23%1.59M

122.75%1.6M

-73.27%39.29M

Change In working capital

53.54%-36.83M

111.66%6.37M

-417.69%-27.62M

61.60%-6.23M

45.40%-9.35M

-287.10%-79.26M

-165.00%-54.61M

-73.10%8.69M

-166.87%-16.22M

-367.79%-17.12M

-Change in receivables

-1,254.48%-150.68M

-134.38%-44.06M

-406.97%-75.28M

-3,084.96%-39.88M

42.36%8.53M

-61.68%13.05M

-240.91%-18.8M

347.56%24.52M

194.08%1.34M

-64.05%5.99M

-Change in inventory

1.30%-46.73M

-20.44%-11.79M

17.67%-19.23M

-16.04%-13.04M

9.82%-2.67M

-657.20%-47.35M

-6.56%-9.79M

-443.63%-23.35M

-249.52%-11.24M

73.97%-2.96M

-Change in prepaid assets

203.08%18.18M

83.46%3.37M

149.25%9.72M

-84.72%1.17M

153.06%3.92M

-1,058.11%-17.64M

-69.11%1.84M

-215.74%-19.74M

492.64%7.65M

-193.95%-7.38M

-Change in payables and accrued expense

621.21%142.41M

311.21%58.85M

109.62%57.16M

425.95%45.53M

-49.84%-19.12M

-269.98%-27.32M

9.28%-27.86M

3.70%27.27M

-182.79%-13.97M

-452.64%-12.76M

Cash from discontinued investing activities

Operating cash flow

27.47%-174.88M

87.06%-12.94M

-46.40%-54.3M

22.23%-38.92M

-27.18%-68.73M

-544.17%-241.12M

-91.03%-99.95M

-370.51%-37.09M

-26,515.43%-50.04M

-4,053.55%-54.05M

Investing cash flow

Cash flow from continuing investing activities

186.69%144.64M

127.10%35.2M

11,160.39%50.55M

4,800.57%41.37M

149.21%17.53M

-20.55%-166.85M

-220.85%-129.9M

-102.86%-457K

-103.73%-880K

87.52%-35.62M

Net PPE purchase and sale

127.42%559K

148.28%42K

133.04%151K

138.64%340K

104.23%26K

-58.18%-2.04M

81.41%-87K

-75.10%-457K

-112.05%-880K

-324.14%-615K

Net business purchase and sale

--7M

--0

----

--0

----

Net investment purchase and sale

208.44%138.14M

128.43%36.21M

--43.4M

--41.03M

--17.5M

-11,263.25%-127.38M

-217.99%-127.38M

--0

Net other investing changes

97.19%-1.05M

----

72.48%-37.43M

---2.43M

--0

75.86%-35M

Cash from discontinued investing activities

Investing cash flow

186.69%144.64M

127.10%35.2M

11,160.39%50.55M

4,800.57%41.37M

149.21%17.53M

-20.55%-166.85M

-220.85%-129.9M

-102.86%-457K

-103.73%-880K

87.52%-35.62M

Financing cash flow

Cash flow from continuing financing activities

28.12%69.6M

-94.45%366K

-77.28%11.11M

7,434.67%54.33M

305.07%3.8M

4.72%54.33M

343.38%6.59M

4,338.42%48.87M

-98.46%721K

-176.06%-1.86M

Net issuance payments of debt

--0

--49.93M

--0

--49.49M

--0

--440K

Net common stock issuance

1,028.00%71.72M

-101.65%-105K

--11.44M

--53.55M

--6.84M

-84.46%6.36M

--6.36M

--0

Proceeds from stock option exercised by employees

-16.87%2.5M

37.38%996K

-32.91%53K

-18.76%1.35M

-81.07%103K

-77.53%3.01M

-57.10%725K

-93.83%79K

-72.75%1.66M

-87.43%544K

Net other financing activities

7.06%-4.62M

-7.14%-525K

45.08%-385K

38.75%-577K

-10.39%-3.13M

-105.03%-4.97M

-141.38%-490K

-291.62%-701K

-515.69%-942K

-50.21%-2.84M

Cash from discontinued financing activities

Financing cash flow

28.12%69.6M

-94.45%366K

-77.28%11.11M

7,434.67%54.33M

305.07%3.8M

4.72%54.33M

343.38%6.59M

4,338.42%48.87M

-98.46%721K

-176.06%-1.86M

Net cash flow

Beginning cash position

-84.68%63.99M

-71.90%80.71M

-73.41%73.36M

-94.91%16.59M

-84.68%63.99M

-22.89%417.64M

-20.43%287.25M

-16.43%275.92M

25.47%326.12M

-22.89%417.64M

Current changes in cash

111.13%39.36M

110.14%22.63M

-35.07%7.35M

213.11%56.78M

48.20%-47.4M

-185.29%-353.65M

-494.07%-223.26M

-63.25%11.32M

-171.45%-50.2M

67.51%-91.52M

End cash Position

61.51%103.34M

-71.90%80.71M

-73.41%73.36M

-94.91%16.59M

-84.68%63.99M

-20.43%287.25M

-16.43%275.92M

25.47%326.12M

Free cash flow

27.96%-175.17M

87.03%-12.97M

-44.62%-54.3M

23.38%-39.02M

-26.02%-68.88M

-527.99%-243.16M

-89.51%-100.04M

-379.15%-37.55M

-8,343.95%-50.92M

-4,573.00%-54.66M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	27.47%-174.88M	87.06%-12.94M	-46.40%-54.3M	22.23%-38.92M	-27.18%-68.73M	-544.17%-241.12M	-91.03%-99.95M	-370.51%-37.09M	-26,515.43%-50.04M	-4,053.55%-54.05M
Net income from continuing operations	18.46%-237.89M	-35.30%-79.65M	54.25%-39.64M	14.52%-42.87M	21.18%-75.73M	-1.62%-291.75M	-28.75%-58.87M	-124.90%-86.65M	-67.73%-50.15M	44.44%-96.08M
Operating gains losses	----	----	----	----	----	--6.22M	--0	--0	--0	--6.22M
Depreciation and amortization	2.49%3.79M	1.24%1.06M	-9.65%899K	-0.79%880K	23.73%949K	7.09%3.7M	25.60%1.05M	11.55%995K	1.14%887K	-9.66%767K
Other non cash items	-92.29%3.39M	-67.86%477K	-22.33%1.24M	-70.70%468K	-96.92%1.21M	-69.27%43.96M	24.29%1.48M	-16.23%1.59M	122.75%1.6M	-73.27%39.29M
Change In working capital	53.54%-36.83M	111.66%6.37M	-417.69%-27.62M	61.60%-6.23M	45.40%-9.35M	-287.10%-79.26M	-165.00%-54.61M	-73.10%8.69M	-166.87%-16.22M	-367.79%-17.12M
-Change in receivables	-1,254.48%-150.68M	-134.38%-44.06M	-406.97%-75.28M	-3,084.96%-39.88M	42.36%8.53M	-61.68%13.05M	-240.91%-18.8M	347.56%24.52M	194.08%1.34M	-64.05%5.99M
-Change in inventory	1.30%-46.73M	-20.44%-11.79M	17.67%-19.23M	-16.04%-13.04M	9.82%-2.67M	-657.20%-47.35M	-6.56%-9.79M	-443.63%-23.35M	-249.52%-11.24M	73.97%-2.96M
-Change in prepaid assets	203.08%18.18M	83.46%3.37M	149.25%9.72M	-84.72%1.17M	153.06%3.92M	-1,058.11%-17.64M	-69.11%1.84M	-215.74%-19.74M	492.64%7.65M	-193.95%-7.38M
-Change in payables and accrued expense	621.21%142.41M	311.21%58.85M	109.62%57.16M	425.95%45.53M	-49.84%-19.12M	-269.98%-27.32M	9.28%-27.86M	3.70%27.27M	-182.79%-13.97M	-452.64%-12.76M
Cash from discontinued investing activities
Operating cash flow	27.47%-174.88M	87.06%-12.94M	-46.40%-54.3M	22.23%-38.92M	-27.18%-68.73M	-544.17%-241.12M	-91.03%-99.95M	-370.51%-37.09M	-26,515.43%-50.04M	-4,053.55%-54.05M
Investing cash flow
Cash flow from continuing investing activities	186.69%144.64M	127.10%35.2M	11,160.39%50.55M	4,800.57%41.37M	149.21%17.53M	-20.55%-166.85M	-220.85%-129.9M	-102.86%-457K	-103.73%-880K	87.52%-35.62M
Net PPE purchase and sale	127.42%559K	148.28%42K	133.04%151K	138.64%340K	104.23%26K	-58.18%-2.04M	81.41%-87K	-75.10%-457K	-112.05%-880K	-324.14%-615K
Net business purchase and sale	--7M	--0	----	----	----	--0	--0	----	----	----
Net investment purchase and sale	208.44%138.14M	128.43%36.21M	--43.4M	--41.03M	--17.5M	-11,263.25%-127.38M	-217.99%-127.38M	--0	--0	--0
Net other investing changes	97.19%-1.05M	----	----	----	----	72.48%-37.43M	---2.43M	--0	--0	75.86%-35M
Cash from discontinued investing activities
Investing cash flow	186.69%144.64M	127.10%35.2M	11,160.39%50.55M	4,800.57%41.37M	149.21%17.53M	-20.55%-166.85M	-220.85%-129.9M	-102.86%-457K	-103.73%-880K	87.52%-35.62M
Financing cash flow
Cash flow from continuing financing activities	28.12%69.6M	-94.45%366K	-77.28%11.11M	7,434.67%54.33M	305.07%3.8M	4.72%54.33M	343.38%6.59M	4,338.42%48.87M	-98.46%721K	-176.06%-1.86M
Net issuance payments of debt	--0	--0	--0	--0	--0	--49.93M	--0	--49.49M	--0	--440K
Net common stock issuance	1,028.00%71.72M	-101.65%-105K	--11.44M	--53.55M	--6.84M	-84.46%6.36M	--6.36M	--0	--0	--0
Proceeds from stock option exercised by employees	-16.87%2.5M	37.38%996K	-32.91%53K	-18.76%1.35M	-81.07%103K	-77.53%3.01M	-57.10%725K	-93.83%79K	-72.75%1.66M	-87.43%544K
Net other financing activities	7.06%-4.62M	-7.14%-525K	45.08%-385K	38.75%-577K	-10.39%-3.13M	-105.03%-4.97M	-141.38%-490K	-291.62%-701K	-515.69%-942K	-50.21%-2.84M
Cash from discontinued financing activities
Financing cash flow	28.12%69.6M	-94.45%366K	-77.28%11.11M	7,434.67%54.33M	305.07%3.8M	4.72%54.33M	343.38%6.59M	4,338.42%48.87M	-98.46%721K	-176.06%-1.86M
Net cash flow
Beginning cash position	-84.68%63.99M	-71.90%80.71M	-73.41%73.36M	-94.91%16.59M	-84.68%63.99M	-22.89%417.64M	-20.43%287.25M	-16.43%275.92M	25.47%326.12M	-22.89%417.64M
Current changes in cash	111.13%39.36M	110.14%22.63M	-35.07%7.35M	213.11%56.78M	48.20%-47.4M	-185.29%-353.65M	-494.07%-223.26M	-63.25%11.32M	-171.45%-50.2M	67.51%-91.52M
End cash Position	61.51%103.34M	61.51%103.34M	-71.90%80.71M	-73.41%73.36M	-94.91%16.59M	-84.68%63.99M	-84.68%63.99M	-20.43%287.25M	-16.43%275.92M	25.47%326.12M
Free cash flow	27.96%-175.17M	87.03%-12.97M	-44.62%-54.3M	23.38%-39.02M	-26.02%-68.88M	-527.99%-243.16M	-89.51%-100.04M	-379.15%-37.55M	-8,343.95%-50.92M	-4,573.00%-54.66M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall